{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T07:15:23Z","timestamp":1783754123202,"version":"3.55.0"},"reference-count":42,"publisher":"Informa UK Limited","issue":"5","license":[{"start":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T00:00:00Z","timestamp":1645660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2022,3,24]]},"DOI":"10.1080\/14656566.2022.2043273","type":"journal-article","created":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T02:59:17Z","timestamp":1645757957000},"page":"535-541","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":6,"title":["The evidence to date on umbralisib for the treatment of refractory marginal zone lymphoma and follicular lymphoma"],"prefix":"10.1080","volume":"23","author":[{"given":"Janelle","family":"Schweitzer","sequence":"first","affiliation":[{"name":"Veterans Affairs Puget Sound Health Care System","place":["Seattle, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Hoffman","sequence":"additional","affiliation":[{"name":"Veterans Affairs Puget Sound Health Care System","place":["Seattle, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solomon A.","family":"Graf","sequence":"additional","affiliation":[{"name":"Veterans Affairs Puget Sound Health Care System","place":["Seattle, USA"]},{"name":"University of Washington School of Medicine","place":["Seattle, USA"]},{"name":"Fred Hutchinson Cancer Research Center","place":["Seattle, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,2,24]]},"reference":[{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21357"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.7.2332"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1614598"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)62175-7"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24492"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.76.8853"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.7534"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-12-4434"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2007.06.009"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-021-00209-1"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.07.029"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-05-786566"},{"issue":"7","key":"e_1_3_3_15_1","first-page":"1525","article-title":"FDA approval: idelalisib monotherapy for the treatment of patients with follicular lymphoma and small lymphocytic lymphoma","volume":"21","author":"Bw M","year":"2015","unstructured":"Bw M, P D, de C RA, et al. FDA approval: idelalisib monotherapy for the treatment of patients with follicular lymphoma and small lymphocytic lymphoma. J Clin Oncol. 2015;21(7):1525\u20131529.","journal-title":"J Clin Oncol"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1314583"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.75.4648"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25711"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00915"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2019.0029"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-707133"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2021.1948038"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1813904"},{"key":"e_1_3_3_24_1","volume-title":"Idelalisib [package insert]","year":"2014","unstructured":"Idelalisib [package insert]. Foster City CA: Gilead Sciences, Inc; 2014. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2014\/206545lbl.pdf"},{"key":"e_1_3_3_25_1","volume-title":"Copanlisib [package insert]","year":"2017","unstructured":"Copanlisib [package insert]. Hippany NJ: Bayer HealthCare Pharmaceutical, Inc; 2017. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/209936s000lbl.pdf"},{"key":"e_1_3_3_26_1","volume-title":"Duvelisib [package insert]","year":"2018","unstructured":"Duvelisib [package insert]. Needham MA: Verastem, Inc; 2018. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/211155s000lbl.pdf"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30082-2"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-08-731240"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21239026"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.03433"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-10-747345"},{"key":"e_1_3_3_32_1","first-page":"5332","article-title":"Integrated safety analysis of umbralisib, adual PI3K\u03b4\/CK1\u03b5 inhibitor, in relapsed\/refractory lymphoid malignancies","volume":"5","author":"Davids M","year":"2021","unstructured":"Davids M, O\u2019Connor OA, and Jurczak, et al. Integrated safety analysis of umbralisib, adual PI3K\u03b4\/CK1\u03b5 inhibitor, in relapsed\/refractory lymphoid malignancies. Blood. 2021; 5(23):5332\u20135343.","journal-title":"Blood."},{"key":"e_1_3_3_33_1","volume-title":"Umbralisib [package insert]","year":"2021","unstructured":"Umbralisib [package insert]. Edison NJ: TG Therapeutics, Inc; 2021. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/213176s000lbl.pdf"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.7534"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.237990"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-08-822148"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00010"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1805104"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy458"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019001299"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2858"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-06-860593"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2021.1966782"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1200\/GO.20.00423"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2022.2043273","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14656566.2022.2043273","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2022.2043273","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T06:50:29Z","timestamp":1783752629000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2022.2043273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,24]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,3,24]]}},"alternative-id":["10.1080\/14656566.2022.2043273"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2022.2043273","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,24]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-11-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}